2024-09-11 - Analysis Report
## GILD Stock Analysis Report

**Company Overview:** Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that develops, manufactures, and commercializes drugs for the treatment of life-threatening diseases. 

**Performance Analysis:**

1. **Performance vs. S&P 500:**
    * **Cumulative Return:** GILD: 14.66%, VOO: 83.37%
    * **Relative Performance:** GILD has underperformed VOO by 68.71%. This represents a relative performance position within the 21.23% percentile of its historical range.

2. **Recent Price Trends:**
    * **Closing Price:** $79.17
    * **Moving Averages:**
        * 5-day: $79.10
        * 20-day: $76.63
        * 60-day: $72.98

3. **Technical Indicators:**
    * **RSI:** 81.13 (Overbought territory)
    * **PPO:** 0.1 (Neutral)
    * **Delta_Previous_Relative_Divergence:** 3.23 (Short-term bullish)
    * **Expected Return:** 19.91% (Maximum 5-year expected return on current investment)

4. **Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 1.29 | 6.95 B$ |
| 2024-05-08 | -3.34 | 6.69 B$ |
| 2023-11-07 | 1.75 | 7.05 B$ |
| 2023-08-04 | 0.84 | 6.60 B$ |
| 2024-08-08 | 0.84 | 6.60 B$ |

* The most recent earnings report (2024-08-08) showed a positive EPS of 1.29, beating analyst expectations. Revenue came in at 6.95 B$, also exceeding forecasts.

**Overall Analysis:**

GILD's performance has significantly lagged behind the S&P 500. Despite recent positive earnings, the stock remains overbought with a high RSI. While the Delta_Previous_Relative_Divergence suggests a short-term bullish outlook and the expected return is promising, investors should exercise caution due to the current overbought condition. 

**Recommendation:**

Given the current overbought territory and lagging performance against the market, investors should consider a cautious approach to GILD. Although the latest earnings beat expectations and the projected return is positive, the RSI suggests potential for a short-term correction. Monitoring further price action and technical indicators will be crucial before making any investment decisions.
